Results 281 to 290 of about 308,193 (309)
Some of the next articles are maybe not open access.

HLA epitopes and graft survival.

Clinical transplants, 1992
1. The fraction of patients and graft survival was provided for amino acid residues, heptapeptides, and conformational epitopes with HLA specificities of up to 7 antigens mismatched. 2. Mismatching large numbers of serologically defined residues was detrimental to graft survival, whereas nonserologically defined residues did not have an effect. 3.
S, Takemoto, P I, Terasaki
openaire   +1 more source

Fifteen-year kidney graft survival.

Clinical transplants, 1991
1. Among patients transplanted in 93 selected centers with good follow-up data, the 10-year graft survival of first cadaver-donor transplants was 18%, parental donor grafts 39%, and HLA-identical sibling donor grafts 66%. The respective half-lives were 6.8, 10.8, and 24.5 years.
Y W, Cho, P I, Terasaki, B, Graver
openaire   +1 more source

GRAFT SURVIVAL ISHRS2018

2018
Garg, Seema, Garg, Anil
openaire   +1 more source

ANALYSING RENAL-GRAFT SURVIVAL

The Lancet, 1978
M.J.R Healy, J.H Roger
openaire   +1 more source

Survival outcomes used to generate version 9 American Joint Committee on Cancer staging system for anal cancer

Ca-A Cancer Journal for Clinicians, 2023
Lauren Janczewski   +2 more
exaly  

Survival outcomes used to validate version 9 of the American Joint Committee on Cancer staging system for appendiceal cancer

Ca-A Cancer Journal for Clinicians, 2023
Lauren Janczewski   +2 more
exaly  

Young Adult Oncology: The Patients and Their Survival Challenges

Ca-A Cancer Journal for Clinicians, 2007
W Archie Bleyer
exaly  

Home - About - Disclaimer - Privacy